The news of him testing positive after administering a trial dose has raised questions about Bharat Biotech's vaccine's effectiveness. The vaccine efficacy will be determined two weeks after the second dose, it said. I am admitted to Civil Hospital Ambala Cantt. And full antibodies are developed 14 days after the second dose is given.
Vij had offered to be the first volunteer in the phase three human trials for the potential coronavirus vaccine Covaxin in which over 25,000 persons were administered trial doses.
"COVAXIN has been created to be protective 2 weeks after volunteers receive the 2nd dose". "The phase-3 trials are double-blinded and randomized, where 50% of subjects (participants in the trial) receive vaccine & 50% of subjects receive placebo".
Hospital selected as Covid-19 vaccination hub
How will states decide which vaccines go where? Hospitals treated six COVID-19 patients in September, and 14 in October. Then, each box must be unpacked manually and the temperature downloaded to check if it hasn't changed in transit.
"I have been tested Corona positive".
On November 16, Bharat Biotech had announced the beginning of the phase 3 clinical trials Covaxin in India, with 26,000 participants from across 22 sites in the country.
The 67-year-old is a senior leader of the ruling Bharatiya Janata Party (BJP) and a legislator from Ambala Cantt assembly constituency. On December 2, the United Kingdom became the first country to approve the Pfizer-BioNTech vaccine against COVID-19 for emergency supply.
In clarification, the Hyderabad-based pharmaceutical company also said: "The phase three trial is a double-blind study where volunteers have a 50 per cent chance of receiving either vaccine or placebo". National Institute of Virology, Pune, isolated the inactivated strain and then ICMR transferred it to Biotech Bharat on May 9.
Haryana state has so far reported 240,841 cases of COVID-19 and 2,539 related deaths.